Data as of Mar 11
| +2.01 / +8.05%|
The 4 analysts offering 12-month price forecasts for Medifast Inc have a median target of 31.00, with a high estimate of 37.00 and a low estimate of 27.00. The median estimate represents a +14.94% increase from the last price of 26.97.
The current consensus among 4 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.